Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
20.69
+0.41 (2.02%)
Apr 1, 2025, 2:45 PM CST

SHA:600161 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
2,6864,5553,7134,3301,748
Upgrade
Cash & Short-Term Investments
2,6864,5553,7134,3301,748
Upgrade
Cash Growth
-41.04%22.68%-14.25%147.68%23.69%
Upgrade
Accounts Receivable
1,12194.131,1731,027695.59
Upgrade
Other Receivables
13.4539.0828.3622.2716.93
Upgrade
Receivables
1,134133.211,2011,050712.52
Upgrade
Inventory
3,8692,8442,3322,1442,172
Upgrade
Other Current Assets
33.436.5324.8722.2723.64
Upgrade
Total Current Assets
7,7227,5697,2717,5464,656
Upgrade
Property, Plant & Equipment
5,8484,8864,0552,6311,997
Upgrade
Long-Term Investments
143.2146.06146.06146.06121.59
Upgrade
Goodwill
572.15173.92173.92127.93115.01
Upgrade
Other Intangible Assets
917.05686.88441.63370.99252.44
Upgrade
Long-Term Deferred Tax Assets
41.7746.7460.6367.0163.11
Upgrade
Long-Term Deferred Charges
507.82470.26552.69362.46174.08
Upgrade
Other Long-Term Assets
117.66208.66228.88326.85161.34
Upgrade
Total Assets
15,87014,18812,92911,5787,541
Upgrade
Accounts Payable
81.45179.169.3973.745.86
Upgrade
Accrued Expenses
21.87168.69163.21150.02146.85
Upgrade
Short-Term Debt
----200.13
Upgrade
Current Portion of Long-Term Debt
8.96-112.99108.15126.25
Upgrade
Current Portion of Leases
-17.9510.8216.51-
Upgrade
Current Income Taxes Payable
222.2461.8573.7944.8636.63
Upgrade
Current Unearned Revenue
213.19357.26292.72215.31200.66
Upgrade
Other Current Liabilities
572.63494.78434.44201.03182.98
Upgrade
Total Current Liabilities
1,1201,2801,157809.58939.36
Upgrade
Long-Term Debt
--253.75366.25474.59
Upgrade
Long-Term Leases
44.8624.4225.6218.01-
Upgrade
Long-Term Unearned Revenue
107.4499.56101.992.6980.83
Upgrade
Long-Term Deferred Tax Liabilities
62.4428.8530.8720.1411.15
Upgrade
Other Long-Term Liabilities
1.241.244.14.14.1
Upgrade
Total Liabilities
1,3361,4341,5741,3111,510
Upgrade
Common Stock
1,9771,6481,6481,3731,254
Upgrade
Additional Paid-In Capital
2,4632,7932,7933,067274.62
Upgrade
Retained Earnings
6,6985,3824,3553,6122,989
Upgrade
Comprehensive Income & Other
-0.1-0.1-0.1-0.1-0.1
Upgrade
Total Common Equity
11,1399,8238,7958,0524,518
Upgrade
Minority Interest
3,3942,9322,5602,2151,513
Upgrade
Shareholders' Equity
14,53312,75411,35610,2676,031
Upgrade
Total Liabilities & Equity
15,87014,18812,92911,5787,541
Upgrade
Total Debt
53.8242.37403.17508.92800.97
Upgrade
Net Cash (Debt)
2,6324,5133,3103,821947.15
Upgrade
Net Cash Growth
-41.68%36.34%-13.38%303.40%-6.48%
Upgrade
Net Cash Per Share
1.332.271.661.970.52
Upgrade
Filing Date Shares Outstanding
1,9911,9771,9771,9771,806
Upgrade
Total Common Shares Outstanding
1,9911,9771,9771,9771,806
Upgrade
Working Capital
6,6026,2906,1136,7363,717
Upgrade
Book Value Per Share
5.594.974.454.072.50
Upgrade
Tangible Book Value
9,6508,9628,1807,5534,150
Upgrade
Tangible Book Value Per Share
4.854.534.143.822.30
Upgrade
Buildings
-2,2411,957963.02949.32
Upgrade
Machinery
-2,2181,9961,2581,177
Upgrade
Construction In Progress
-2,0441,5321,6231,030
Upgrade
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.